Embolization and chemoembolization therapy for neuroendocrine tumors

Area of Science:

• Oncology
• Hepatology
• Interventional Radiology

Background:

• Neuroendocrine tumors frequently metastasize to the liver, significantly impacting patient prognosis.
• Hepatic metastases often dictate the clinical course due to hormone secretion or tumor burden.
• The liver's dual vascular supply, with metastases primarily fed by the hepatic artery, presents a therapeutic target.

Purpose of the Study:

• To evaluate the efficacy of chemoembolization for managing liver-dominant neuroendocrine metastases.
• To explore the benefits of regional chemotherapy delivery and tumor vessel embolization.

Main Methods:

• Regional chemotherapy administration via the hepatic artery for pharmacokinetic advantages.
• Selective embolization of tumor vessels to induce ischemia.
• Combination therapy: chemoembolization.

Main Results:

• Chemoembolization demonstrated a reduction in tumor bulk.
• Significant decreases in hormone levels were observed in treated patients.
• Palliative effects on symptoms were noted in a majority of patients with liver-dominant neuroendocrine metastases.

Conclusions:

• Chemoembolization is an effective therapeutic modality for select patients with neuroendocrine tumor liver metastases.
• This approach offers advantages in managing liver-dominant disease, reducing tumor burden and hormonal activity.